Analysts think RCEL stock price could increase by 87%
Mar 21, 2025, 11:25 AM
-0.86%
What does RCEL do
AVITA Medical, headquartered in Valencia, California, specializes in point-of-care autologous skin restoration using its RECELL platform for treating burn injuries and skin defects. The company went public on March 18, 2012, and employs 207 people.
6 analysts think RCEL stock price will increase by 86.65%. The current median analyst target is $17.34 compared to a current stock price of $9.29. The lowest analysts target is $14.14 and the highest analyst target is $23.10.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
